{"id":942703,"date":"2026-03-06T16:04:33","date_gmt":"2026-03-06T21:04:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\/"},"modified":"2026-03-06T16:04:33","modified_gmt":"2026-03-06T21:04:33","slug":"inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\/","title":{"rendered":"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm for More Information \u2013 INO"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, March  06, 2026  (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of\u00a0<strong>Inovio Pharmaceuticals, Inc. (NASDAQ: INO).<\/strong><\/p>\n<p>Shareholders who purchased shares of INO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.<\/p>\n<p align=\"center\">CONTACT US HERE:<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1vbsFDmJpzB9nOMQ-uZ5CuFruGliTz-VX0999-Y1qhzN17GG1HkVLnfxYYGPxU-wGg7RGuvnB-x59nzcgRfLhoVJARB8ANYvS94YMG1zN8JCHMQx4WALACH2NPEeLZ_cOQOO0Wqgsvr28vTB1XrnMHrYjqi3tUbNDUkrZQPWK8x14ioZf8XYRQpC0gJaJGut8rV_Sg4Anlksz_fcixvtfAvmp1Rlj3kAKbmAM4IeBZ-ZgwzcFbWokz20g43Z1I47vEze_LGEucqPDmNTgtorfNvuQA-IFwbnoEOWFJTdZ6x7ggbHEp3pysJQRdlk-9E1S30gcIXEuNS_X--lwkX_BA==\" rel=\"nofollow\" target=\"_blank\">https:\/\/securitiesclasslaw.com\/securities\/inovio-pharmaceuticals-inc-loss-submission-form-2\/?id=184113&amp;from=3<\/a>\n      <\/p>\n<p>\n        <strong>CLASS PERIOD: <\/strong>October 10, 2023 to December 26, 2025<\/p>\n<p>\n        <strong>ALLEGATIONS: <\/strong>The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (i) manufacturing for Inovio\u2019s CELLECTRA device was deficient; (ii) accordingly, Inovio was unlikely to submit it&#8217;s lead product candidate, INO-3107 BLA to the FDA by the second half of 2024; (iii) Inovio had insufficient information to justify the INO-3107 BLA\u2019s eligibility for FDA accelerated approval or priority review; (iv) accordingly, INO-3107\u2019s overall regulatory and commercial prospects were overstated; and (v) as a result, defendants\u2019 public statements were materially false and misleading at all relevant times.<\/p>\n<p>\n        <strong>DEADLINE: April 7, 2026<\/strong> Shareholders should not delay in registering for this class action. Register your information here: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1vbsFDmJpzB9nOMQ-uZ5CuFruGliTz-VX0999-Y1qhzN17GG1HkVLnfxYYGPxU-wGg7RGuvnB-x59nzcgRfLhoVJARB8ANYvS94YMG1zN8JCHMQx4WALACH2NPEeLZ_cOQOO0Wqgsvr28vTB1XrnMAXnNdnFXUFnYspYcWcfHSc0px49h4sykx0JihMtOfBLxFzn-oooTpHUWkBXXpVORIRxRs57H2U7PfJpWgMgfbT8iphLvWm10_RHOa9i6yOmgIxC_VoQQHXcuGaXnVay-gGhuE6u3ghNOkDDDB1-0CCy8lbOf19R0kZ4JQXzVUZyW8V6wLOWcMvTfFk7Fl2d8A==\" rel=\"nofollow\" target=\"_blank\">https:\/\/securitiesclasslaw.com\/securities\/inovio-pharmaceuticals-inc-loss-submission-form-2\/?id=184113&amp;from=3<\/a><\/p>\n<p>\n        <strong>NEXT STEPS FOR SHAREHOLDERS: <\/strong>Once you register as a shareholder who purchased shares of INO during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 7, 2026. There is no cost or obligation to you to participate in this case.<\/p>\n<p>\n        <strong>WHY GROSS LAW FIRM? <\/strong>The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and\/or misleading statements or the omission of material information by a company lead to artificial inflation of the company&#8217;s stock. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>The Gross Law Firm<br \/>15 West 38th Street, 12th floor<br \/>New York, NY, 10018<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oHE0Oji6zxtVneJcMmgTNFK1kXTmMdOSWoO9kDv5fenCCwOo8myNcjl39ieBIsKN2I-Pe3go8_j3RQu2UVZz_jmVn1o420zByRyQFFzb0ZGOFmvivxVop4JZX6lyTZUW\" rel=\"nofollow\" target=\"_blank\">dg@securitiesclasslaw.com<\/a><br \/>Phone: (646) 453-8903<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjgyMyM3NDcwNDU2IzIyNTg5MTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MmUwYmM5YmQtMTVhYy00N2E3LWFjNzAtNzIwYWQ0MThjODRlLTEyNzA0NjctMjAyNi0wMy0wNi1lbg==\/tiny\/The-Gross-Law-Firm.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of\u00a0Inovio Pharmaceuticals, Inc. (NASDAQ: INO). Shareholders who purchased shares of INO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/inovio-pharmaceuticals-inc-loss-submission-form-2\/?id=184113&amp;from=3 CLASS PERIOD: October 10, 2023 to December 26, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (i) manufacturing for Inovio\u2019s CELLECTRA device was deficient; (ii) accordingly, Inovio was unlikely to submit it&#8217;s lead product candidate, INO-3107 BLA to the FDA by the second half of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm for More Information \u2013 INO&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-942703","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm for More Information \u2013 INO - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm for More Information \u2013 INO - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of\u00a0Inovio Pharmaceuticals, Inc. (NASDAQ: INO). Shareholders who purchased shares of INO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/inovio-pharmaceuticals-inc-loss-submission-form-2\/?id=184113&amp;from=3 CLASS PERIOD: October 10, 2023 to December 26, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (i) manufacturing for Inovio\u2019s CELLECTRA device was deficient; (ii) accordingly, Inovio was unlikely to submit it&#8217;s lead product candidate, INO-3107 BLA to the FDA by the second half of &hellip; Continue reading &quot;Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm for More Information \u2013 INO&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-06T21:04:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjgyMyM3NDcwNDU2IzIyNTg5MTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm for More Information \u2013 INO\",\"datePublished\":\"2026-03-06T21:04:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\\\/\"},\"wordCount\":402,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NjgyMyM3NDcwNDU2IzIyNTg5MTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\\\/\",\"name\":\"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm for More Information \u2013 INO - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NjgyMyM3NDcwNDU2IzIyNTg5MTc=\",\"datePublished\":\"2026-03-06T21:04:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NjgyMyM3NDcwNDU2IzIyNTg5MTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NjgyMyM3NDcwNDU2IzIyNTg5MTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm for More Information \u2013 INO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm for More Information \u2013 INO - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\/","og_locale":"en_US","og_type":"article","og_title":"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm for More Information \u2013 INO - Market Newsdesk","og_description":"NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of\u00a0Inovio Pharmaceuticals, Inc. (NASDAQ: INO). Shareholders who purchased shares of INO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/inovio-pharmaceuticals-inc-loss-submission-form-2\/?id=184113&amp;from=3 CLASS PERIOD: October 10, 2023 to December 26, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (i) manufacturing for Inovio\u2019s CELLECTRA device was deficient; (ii) accordingly, Inovio was unlikely to submit it&#8217;s lead product candidate, INO-3107 BLA to the FDA by the second half of &hellip; Continue reading \"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm for More Information \u2013 INO\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\/","og_site_name":"Market Newsdesk","article_published_time":"2026-03-06T21:04:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjgyMyM3NDcwNDU2IzIyNTg5MTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm for More Information \u2013 INO","datePublished":"2026-03-06T21:04:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\/"},"wordCount":402,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjgyMyM3NDcwNDU2IzIyNTg5MTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\/","name":"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm for More Information \u2013 INO - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjgyMyM3NDcwNDU2IzIyNTg5MTc=","datePublished":"2026-03-06T21:04:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjgyMyM3NDcwNDU2IzIyNTg5MTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjgyMyM3NDcwNDU2IzIyNTg5MTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inovio-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-for-more-information-ino\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm for More Information \u2013 INO"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/942703","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=942703"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/942703\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=942703"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=942703"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=942703"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}